Back
Apellis Pharmaceuticals Stock Price Chart
5 Stocks to Consider Immediately (must-see chart)
See the green days for 5 major stocks right here, free of charge
Sell
31
APLS
Apellis Pharmaceuticals
Last Price:
$17.41
Seasonality Move:
-16.64%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.01 | Buy |
| 20-day SMA: | 18.4 | Sell |
| 50-day SMA: | 18.14 | Buy |
| 200-day SMA: | 25.87 | Sell |
| 8-day EMA: | 17.97 | Buy |
| 20-day EMA: | 18.12 | Buy |
| 50-day EMA: | 18.85 | Sell |
| 200-day EMA: | 26.2 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 50.59 | Buy |
| Chaikin Money Flow: | 891120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.6 - 19.1) | Sell |
| Bollinger Bands (100): | (17.22 - 24.96) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.26 while APLS 8-day simple moving average is 18.01, which is a Buy signal.
-
The stock price of APLS is 18.26 while Apellis Pharmaceuticals 20-day SMA is 18.40, which makes it a Sell.
-
Apellis Pharmaceuticals 50-day simple moving average is 18.14 while APLS share price is 18.26, making it a Buy technically.
-
APLS stock price is 18.26 and Apellis Pharmaceuticals 200-day simple moving average is 25.87, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $18.26. The Score for APLS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.3B
Price in USD:
18.26
Share Volume:
891.1K
Apellis Pharmaceuticals 52-Week Range
52-Week High:
42.47
52-Week Low:
16.10
Sell
31
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 18.26 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 18.26 while APLS 8-day exponential moving average is 17.97, which is a Buy signal.
-
The stock price of APLS is 18.26 while Apellis Pharmaceuticals 20-day EMA is 18.12, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 18.85 while APLS share price is 18.26, making it a Sell technically.
-
APLS stock price is 18.26 and Apellis Pharmaceuticals 200-day simple moving average is 26.20, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.24 per share, and an increase next year of $0.74 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Apellis Pharmaceuticals is a Sell
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 50.59, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.6 - 19.1), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (17.22 - 24.96), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.